05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceuticals and therapeutic agents for the treatment and
prevention of diseases and medical conditions, namely,
infectious disease, autoimmune disease, inflammatory
disease, immune disorders, allergic disorders, cancer,
immuno-oncology, metabolic disorders, digestive disorders,
neurological disorders, and cardiovascular disorders;
pharmaceutical and biopharmaceutical agents, namely,
microbiologics, immunotherapeutics, live biotherapeutic
products and other therapeutic agents for the treatment and
prevention of diseases and medical conditions, namely,
infectious disease, autoimmune disease, inflammatory
disease, immune disorders, allergic disorders, cancer,
immuno-oncology, metabolic disorders, digestive disorders,
neurological disorders, and cardiovascular disorders;
pharmaceuticals in the nature of cultures of microorganisms
for medical use.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceuticals and therapeutic agents for the treatment and
prevention of diseases and medical conditions, namely,
infectious disease, autoimmune disease, inflammatory
disease, immune disorders, allergic disorders, cancer,
immuno-oncology, metabolic disorders, digestive disorders,
neurological disorders, and cardiovascular disorders;
Pharmaceutical and biopharmaceutical agents, namely,
microbiologics, immunotherapeutics, live biotherapeutic
products and other therapeutic agents for the treatment and
prevention of diseases and medical conditions, namely,
infectious disease, autoimmune disease, inflammatory
disease, immune disorders, allergic disorders, cancer,
immuno-oncology, metabolic disorders, digestive disorders,
neurological disorders, and cardiovascular disorders;
Pharmaceuticals in the nature of cultures of microorganisms
for medical use.
3.
COMPOSITIONS AND METHODS FOR DECREASING DYSBIOSIS AND/OR PREVENTING INFLAMMATORY BOWEL DISEASE
Provided herein are compositions comprising bacterial mixtures of strains from genera including Roseburia, Dorea, Bacteroides, Coprobacter, Agathobaculum, Lawsonibacter, Tyzzerella, Phascolarctobacterium, Enorma, Faecalimonas, lllomasclavelia, Clostridium, Fournierella, and/or Massilimicrobiota. Also provided are methods of using compositions comprising such bacterial mixtures. In some embodiments, it includes compositions, kits, and methods that are useful, e.g., for treatment and/or prevention of inflammatory bowel disease (IBD), such as ulcerative colitis (UC).
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Pharmaceuticals and therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, live biotherapeutic products and other therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; pharmaceuticals in the nature of cultures of microorganisms for medical use.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Pharmaceuticals and therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, live biotherapeutic products and other therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceuticals in the nature of cultures of microorganisms for medical use.
6.
METHODS OF DECREASING DYSBIOSIS AND RESTORING A MICROBIOME
Provided herein are methods for decreasing dysbiosis, restoring the microbiome, and/or increasing recovery of a healthy microbiome (e.g. following a dysbiosis inducing event), by administering pharmaceutical compositions to a subject. Also provided are methods for protecting the microbiome of a subject and/or colonizing the microbiome of a subject by administering pharmaceutical compositions to the subject.
Provided herein are methods and compositions for decreasing dysbiosis, restoring the microbiome, and/or increasing recovery of a healthy microbiome (e.g., following a dysbiosis inducing event), by administering compositions to a subject. Also provided are methods for protecting the microbiome of a subject and/or colonizing the microbiome of a subject by administering compositions to the subject.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceuticals and therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, live biotherapeutic products and other therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceuticals in the nature of cultures of microorganisms for medical use
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceuticals and therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, live biotherapeutic products and other therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceuticals in the nature of cultures of microorganisms for medical use
10.
COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS
Provided herein are compositions and methods for the suppression of multi-drug resistant organisms. Provided herein are compositions and methods for treating diseases or disorders associated with bacterial colonization or treating diseases or disorders associated with an immune response induced by bacteria. Also provided herein are compositions and methods for suppressing colonization of the intestine of subject with oral microbiome bacteria.
Provided herein are methods and compositions for treating cancer, such as gastric cancer, in a subject involving administering a composition comprising a purified bacterial mixture.
C12Q 1/04 - Détermination de la présence ou du type de micro-organismeEmploi de milieux sélectifs pour tester des antibiotiques ou des bactéricidesCompositions à cet effet contenant un indicateur chimique
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
13.
CLOSTRIDIUM DIFFICILE INFECTION, NEUTROPENIA, CARDIOVASCULAR DISEASE, ASTHMA, AND/OR CANCER
Clostridium difficilee.ge.g., atherosclerosis and/or stroke), asthma, and/or cancer involving administering to a subject a pharmaceutical composition comprising a purified bacterial mixture.
Provided herein are compositions and methods for suppressing infection by pathogenic organisms. Also provided herein are compositions and methods for reducing or preventing colonization by pathogenic organisms and methods of treating infection by a pathogenic organism. Also provided herein are compositions comprising taurine and methods of using such compositions for suppressing infection by pathogenic organisms, preventing colonization by pathogenic organisms, and methods of treating infection pathogenic organisms.
The disclosure relates to methods for colonizing a microbiome, by administering pharmaceutical compositions comprising a purified bacterial mixture to the subject. Also provided are methods for treating and/or preventing inflammatory bowel disease, methods for reducing the risk of inflammatory bowel disease and/or reducing the occurrence of inflammatory bowel disease in a subject by administering pharmaceutical compositions comprising a purified bacterial mixture to the subject. Also provided are methods for treating and/or preventing graft versus host disease in a subject by administering pharmaceutical compositions comprising a purified bacterial mixture to the subject.
A61K 38/14 - Peptides contenant des radicaux saccharideLeurs dérivés
A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
A61K 35/00 - Préparations médicinales contenant des substances ou leurs produits de réaction de constitution non déterminée
A23K 10/18 - Ajout de micro-organismes ou de leurs produits d’extraction, p. ex. de protéines provenant d’organismes unicellulaires, à des compositions de produits alimentaires de micro-organismes vivants
A23K 50/30 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les porcs
18.
COMPOSITIONS AND METHODS FOR TREATING HEPATIC ENCEPHALOPATHY
Provided herein are methods and compositions for treating and/or preventing hepatic encephalopathy involving administering to a subject a pharmaceutical composition comprising a purified bacterial mixture.
A61K 35/742 - Bactéries sporulées, p. ex. Bacillus coagulans, Bacillus subtilis, clostridium ou Lactobacillus sporogenes
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
The disclosure relates to methods for colonizing a microbiome, by administering pharmaceutical compositions comprising a purified bacterial mixture to the subject. Also provided are methods for treating and/or preventing inflammatory bowel disease, methods for reducing the risk of inflammatory bowel disease and/or reducing the occurrence of inflammatory bowel disease in a subject by administering pharmaceutical compositions comprising a purified bacterial mixture to the subject. Also provided are methods for treating and/or preventing graft versus host disease in a subject by administering pharmaceutical compositions comprising a purified bacterial mixture to the subject.
A61K 35/742 - Bactéries sporulées, p. ex. Bacillus coagulans, Bacillus subtilis, clostridium ou Lactobacillus sporogenes
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
Provided herein are compositions and methods for suppressing pathogenic organisms. Also provided herein are compositions and methods for inducing regulatory T-cells in response to pathogenic organisms and methods of treating a disease or disorder associated with bacterial colonization. Also provided herein are methods of suppressing colonization of the intestine of a subject with oral microbiome bacteria.
The disclosure provides methods and compositions for the preservation of bacteria. Aspects of the present disclosure provide methods of preparing a preserved bacterial composition comprising flash freezing a bacterial composition and lyophilizing the flash frozen bacterial composition to produce a preserved bacterial composition. In some embodiments, the bacterial composition comprises one or more bacterial strains. In some embodiments, the one or more bacterial strains comprise one or more anaerobic bacterial strains. In some embodiments, the anaerobic bacterial strains are strict anaerobic bacteria.
Provided herein are compositions and methods for treating cancer, treating colitis associated with immune checkpoint inhibitor therapy, colonizing the microbiome, and/or restoring the microbiome, by administering compositions or food products to a subject.
A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
C07K 16/28 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire
Provided herein are methods and compositions for treating cancer, such as gastric cancer, in a subject involving administering a composition comprising a purified bacterial mixture.
Provided herein are compositions and methods for suppressing infection by pathogenic organisms. Also provided herein are compositions and methods for reducing or preventing colonization by pathogenic organisms and methods of treating infection by a pathogenic organism. Also provided herein are compositions comprising taurine and methods of using such compositions for suppressing infection by pathogenic organisms, preventing colonization by pathogenic organisms, and methods of treating infection pathogenic organisms.
Provided herein are methods and compositions for treating and/or preventing hepatic encephalopathy involving administering to a subject a pharmaceutical composition comprising a purified bacterial mixture.
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
27.
Methods of decreasing dysbiosis and restoring a microbiome
Provided herein are methods for decreasing dysbiosis, restoring the microbiome, and/or increasing recovery of a healthy microbiome (e.g. following a dysbiosis inducing event), by administering pharmaceutical compositions to a subject. Also provided are methods for protecting the microbiome of a subject and/or colonizing the microbiome of a subject by administering pharmaceutical compositions to the subject.
Provided herein are compositions and methods for the treatment of allergy, such as food allergy. Also provided herein are compositions and methods for modulating an immune response associated with allergy and/or inducing immune tolerance or desensitization to an allergy, such as a food allergy.
Provided herein are compositions and methods for treating cancer, treating colitis associated with immune checkpoint inhibitor therapy, colonizing the microbiome, and/or restoring the microbiome, by administering compositions or food products to a subject.
The disclosure provides methods and compositions for the preservation of bacteria. Aspects of the present disclosure provide methods of preparing a preserved bacterial composition comprising flash freezing a bacterial composition and lyophilizing the flash frozen bacterial composition to produce a preserved bacterial composition. In some embodiments, the bacterial composition comprises one or more bacterial strains. In some embodiments, the one or more bacterial strains comprise one or more anaerobic bacterial strains. In some embodiments, the anaerobic bacterial strains are strict anaerobic bacteria.
Provided herein are compositions and methods for suppressing pathogenic organisms. Also provided herein are compositions and methods for inducing regulatory T-cells in response to pathogenic organisms and methods of treating a disease or disorder associated with bacterial colonization. Also provided herein are methods of suppressing colonization of the intestine of a subject with oral microbiome bacteria.
Provided herein are compositions and methods for the suppression of multi-drug resistant organisms. Provided herein are compositions and methods for treating diseases or disorders associated with bacterial colonization or treating diseases or disorders associated with an immune response induced by bacteria. Also provided herein are compositions and methods for suppressing colonization of the intestine of subject with oral microbiome bacteria.
A23K 10/18 - Ajout de micro-organismes ou de leurs produits d’extraction, p. ex. de protéines provenant d’organismes unicellulaires, à des compositions de produits alimentaires de micro-organismes vivants
A23K 50/30 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les porcs
34.
Compositions and methods for the treatment of allergy
Provided herein are compositions and methods for the treatment of allergy, such as food allergy. Also provided herein are compositions and methods for modulating an immune response associated with allergy and/or inducing immune tolerance or desensitization to an allergy, such as a food allergy.
Provided herein are methods for decreasing dysbiosis, restoring the microbiome, and/or increasing recovery of a healthy microbiome ( e.g. following a dysbiosis inducing event), by administering pharmaceutical compositions to a subject. Also provided are methods for protecting the microbiome of a subject and/or colonizing the microbiome of a subject by administering pharmaceutical compositions to the subject.
The disclosure provides compositions comprising a disaccharide, a nutrient, and a buffer, which may be used for the preservation of bacteria, such as during lyophilization and/or extended storage. Provided herein are methods for preserving bacteria, involving adding bacteria to the compositions and subjecting the compositions to a lyophilization cycle. Also provided herein are methods for generating compositions that may be used, for example for the preservation of bacteria.
A23K 50/30 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les porcs
A23K 10/18 - Ajout de micro-organismes ou de leurs produits d’extraction, p. ex. de protéines provenant d’organismes unicellulaires, à des compositions de produits alimentaires de micro-organismes vivants
38.
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
Provided herein are compositions, methods, and kits for the treatment of cancer. The disclosure also provides compositions, methods, and kits that suppress adverse events caused by anticancer therapy.
Provided herein are compositions and methods for the suppression of multi-drug resistant organisms. Provided herein are compositions and methods for treating diseases or disorders associated with bacterial colonization or treating diseases or disorders associated with an immune response induced by bacteria. Also provided herein are compositions and methods for suppressing colonization of the intestine of subject with oral microbiome bacteria.
C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques
Provided herein are compositions and methods for the treatment of allergy, such as food allergy. Also provided herein are compositions and methods for modulating an immune response associated with allergy and/or inducing immune tolerance or desensitization to an allergy, such as a food allergy.
A61K 39/08 - Clostridium, p. ex. Clostridium tetani
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
Provided herein are compositions and methods for the treatment of allergy, such as food allergy. Also provided herein are compositions and methods for modulating an immune response associated with allergy and/or inducing immune tolerance or desensitization to an allergy, such as a food allergy.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Pharmaceutical and biopharmaceutical agents, namely,
microbiologics, immunotherapeutics, and other therapeutic
agents, for the prevention and treatment of human diseases,
namely, infectious disease, autoimmune disease, inflammatory
disease, immune disorders, allergic disorders, cancer,
immuno-oncology, metabolic disorders, digestive disorders,
neurological disorders, and cardiovascular disorders;
pharmaceuticals in the nature of cultures of microorganisms
for medical and veterinary use; pharmaceuticals used to
maintain health or restore health to a human or animal
subject via treatment of a disturbed microbial community;
biological preparations in the nature of cultures of
microorganisms for medical purposes; cultures and
preparations of microorganisms for medical and veterinary
purposes; diagnostic agents for medical purposes for
assessing whether a human or animal subject has a disturbed
microbial community; therapeutic agents in the nature of
microorganisms for medical use; nutritional food additives
for medical purposes in the nature of microorganisms;
dietary supplements; beverages for medical purposes;
nutritional food bars for meal replacement and medical
purposes. Research and development of microbiologics,
immunotherapeutics, and other therapeutic agents;
development of pharmaceuticals, diagnostics, food additives,
dietary supplements, medical foods, foods for special
dietary use; scientific research and development services
relating to foods and dietary supplements; providing reagent
sample testing and diagnostic services for others in the
fields of science and research related thereto.
A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
A23L 5/00 - Préparation ou traitement des aliments ou produits alimentaires en généralAliments ou produits alimentaires ainsi obtenusLeurs matériaux
A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
A61K 38/14 - Peptides contenant des radicaux saccharideLeurs dérivés
A23K 10/18 - Ajout de micro-organismes ou de leurs produits d’extraction, p. ex. de protéines provenant d’organismes unicellulaires, à des compositions de produits alimentaires de micro-organismes vivants
A23K 50/30 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les porcs
A61K 35/747 - Lactobacilles, p. ex. L. acidophilus ou L. brevis
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 35/742 - Bactéries sporulées, p. ex. Bacillus coagulans, Bacillus subtilis, clostridium ou Lactobacillus sporogenes
A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
A23L 5/00 - Préparation ou traitement des aliments ou produits alimentaires en généralAliments ou produits alimentaires ainsi obtenusLeurs matériaux
A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
A61K 38/14 - Peptides contenant des radicaux saccharideLeurs dérivés
A23K 10/18 - Ajout de micro-organismes ou de leurs produits d’extraction, p. ex. de protéines provenant d’organismes unicellulaires, à des compositions de produits alimentaires de micro-organismes vivants
A23K 50/30 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les porcs
A23L 5/00 - Préparation ou traitement des aliments ou produits alimentaires en généralAliments ou produits alimentaires ainsi obtenusLeurs matériaux
A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
A23K 10/18 - Ajout de micro-organismes ou de leurs produits d’extraction, p. ex. de protéines provenant d’organismes unicellulaires, à des compositions de produits alimentaires de micro-organismes vivants
A23K 50/30 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les porcs
46.
METHODS AND COMPOSITIONS FOR DETERMINING BACTERIAL INTEGRITY
C12Q 1/04 - Détermination de la présence ou du type de micro-organismeEmploi de milieux sélectifs pour tester des antibiotiques ou des bactéricidesCompositions à cet effet contenant un indicateur chimique
05 - Produits pharmaceutiques, vétérinaires et hygièniques
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Pharmaceutical and biopharmaceutical agents, namely,
microbiologics, immunotherapeutics, and other therapeutic
agents, for the prevention and treatment of human diseases;
pharmaceuticals in the nature of cultures of microorganisms
for medical and veterinary use; pharmaceuticals used to
maintain health or restore health to a human or animal
subject via treatment of a disturbed microbial community;
biological preparations in the nature of cultures of
microorganisms for medical purposes; cultures and
preparations of microorganisms for medical and veterinary
purposes; diagnostic agents for medical purposes for
assessing whether a human or animal subject has a disturbed
microbial community; therapeutic agents in the nature of
microorganisms for medical use; nutritional food additives
for medical purposes in the nature of microorganisms;
dietary supplements; beverages for medical purposes;
nutritional food bars for meal replacement and medical
purposes. Research and development of microbiologics,
immunotherapeutics, and other therapeutic agents;
development of pharmaceuticals, diagnostics, food additives,
dietary supplements, medical foods, foods for special
dietary use; scientific research and development services
relating to foods and dietary supplements; providing reagent
sample testing and diagnostic services for others in the
fields of science and research related thereto.
51.
Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
Compositions consisting of bioactive molecules derived from the microbiota of a mammal are provided herein. When administered orally with a colonic delivery system, the compositions are useful for the prophylaxis and treatment of diseases, in particular inflammatory, autoimmune and infectious diseases. The compositions comprise combinations of small molecules and bacterial antigens formulated in colonic delivery systems. Use of the compositions results in any or all of: induction of immune tolerance; strengthening of the gut mucosal barrier integrity; reduction of inflammation; and amelioration of a disease state caused by inflammation, an autoimmune reaction or an infectious agent.
A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
A61K 38/16 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés
G01N 33/569 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour micro-organismes, p. ex. protozoaires, bactéries, virus
05 - Produits pharmaceutiques, vétérinaires et hygièniques
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceuticals in the nature of cultures of microorganisms for medical and veterinary use; Pharmaceuticals used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; biological preparations in the nature of cultures of microorganisms for medical purposes; Cultures and preparations of microorganisms for medical and veterinary purposes; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; Therapeutic agents in the nature of microorganisms for medical use; nutritional food additives for medical purposes in the nature of microorganisms; dietary supplements; beverages for medical purposes; nutritional food bars for meal replacement and medical purposes Research and development of microbiologics, immunotherapeutics, and other therapeutic agents; Development of pharmaceuticals, diagnostics, food additives, dietary supplements, medical foods, foods for special dietary use; Scientific research and development services relating to foods and dietary supplements; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto
05 - Produits pharmaceutiques, vétérinaires et hygièniques
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceuticals in the nature of cultures of microorganisms for medical and veterinary use; Pharmaceuticals used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; biological preparations in the nature of cultures of microorganisms for medical purposes; Cultures and preparations of microorganisms for medical and veterinary purposes; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; Therapeutic agents in the nature of microorganisms for medical use; nutritional food additives for medical purposes in the nature of microorganisms; dietary supplements; beverages for medical purposes; nutritional food bars for meal replacement and medical purposes Research and development of microbiologics, immunotherapeutics, and other therapeutic agents; Development of pharmaceuticals, diagnostics, food additives, dietary supplements, medical foods, foods for special dietary use; Scientific research and development services relating to foods and dietary supplements; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
The disclosure provides methods and compositions for the preservation of bacteria. In particular, provided is a composition comprising a lyoprotectant, a nutrient, an antioxidant, sodium metabisulfite, and a buffer, wherein the buffer is at a pH of 6.7 to 7.3, wherein the lyoprotectant is a disaccharide, but not lactose. Also provided is a method for preserving bacteria comprising (i) adding bacteria to a composition of the disclosure; and (ii) subjecting the composition comprising the bacteria to a lyophilization cycle.
Provided herein are compositions and methods for the treatment of allergy, such as food allergy. Also provided herein are compositions and methods for modulating an immune response associated with allergy and/or inducing immune tolerance or desensitization to an allergy, such as a food allergy.
The disclosure provides methods and compositions for the preservation of bacteria. Aspects of the present disclosure provide methods of preparing a preserved bacterial composition comprising flash freezing a bacterial composition and lyophilizing the flash frozen bacterial composition to produce a preserved bacterial composition. In some embodiments, the bacterial composition comprises one or more bacterial strains. In some embodiments, the one or more bacterial strains comprise one or more anaerobic bacterial strains. In some embodiments, the anaerobic bacterial strains are strict anaerobic bacteria.
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
